Celldex Therapeutics, Inc. (CLDX) quarterly cash flow statement — complete operating, investing & financing history
Celldex Therapeutics, Inc. (CLDX) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -65.03M | -57.41M | -65.59M | -63.94M | -48.63M | -44.01M | -54.37M | -32.48M | -55.34M | -29.33M | -40.64M | -32.53M | -18.99M | -27.2M | -28.57M | -21.76M | -35.19M | -22.24M | -24.53M | -14.52M |
| Operating CF Margin % | - | -260954.55% | -437253.33% | -85253.33% | - | -6028.08% | -7823.31% | -2763.91% | -1734.16% | -1174.02% | -26050% | -787.53% | -1252.01% | -10147.76% | -2954.39% | -1349.16% | -8646.68% | -13646.63% | -14100% | -4348.2% |
| Operating CF Growth % | -33.74% | -30.46% | -20.63% | -96.88% | 12.12% | -50.05% | -33.8% | 0.18% | -191.35% | -7.84% | -42.25% | -49.49% | 46.03% | -22.26% | -16.45% | -49.85% | -114.95% | -86.45% | -35.67% | -178.7% |
| Net Income | -75.56M | -73.5M | -78.69M | -81.32M | -67.04M | -56.6M | -53.8M | -47.09M | -42.12M | -35.84M | -32.81M | -43.31M | -38.26M | -30.5M | -29.36M | -26.49M | -26.78M | -36M | -23.05M | -20.15M |
| Depreciation & Amortization | 1.16M | 902K | 854K | 816K | 824K | 873K | 867K | 819K | 786K | 797K | 775K | 759K | 767K | 756K | 726K | 673K | 671K | 741K | 811K | 777K |
| Stock-Based Compensation | 10.97M | 8.41M | 8.52M | 8.91M | 8.8M | 9.19M | 9.32M | 9.78M | 9.62M | 7.64M | 7.2M | 7.21M | 7.12M | 5.22M | 4.34M | 4.51M | 4.5M | 3.45M | 3.15M | 3.14M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.89M | -39.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -742K | -1.7M | -627K | -882K | -1.01M | -1.69M | -2.26M | -3.36M | -4.33M | -4.74M | -3.31M | -42.07M | 38.26M | -1.16M | -1.26M | -521K | 2K | -5.73M | 236K | -48K |
| Working Capital Changes | -872K | 8.48M | 4.35M | 8.53M | 9.8M | 4.22M | -8.5M | 7.38M | -19.29M | 2.82M | -12.5M | 4.98M | 13.01M | -1.51M | -3.02M | 65K | -13.58M | 15.3M | -5.68M | 1.76M |
| Change in Receivables | -125K | 0 | 1.78M | -1.93M | 0 | 974K | -364K | 152K | 682K | 1.14M | -43K | -2.38M | -134K | 1.2M | -967K | -158K | -92K | 146K | -71K | 25K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -823K | 10.14M | -287K | 4.6M | 13.06M | 2.09M | -8.72M | 7.99M | 6.71M | 1.71M | -4.78M | 3.88M | 8.48M | 478K | -3.45M | 2.4M | 1.58M | 1.88M | -2.74M | 1.9M |
| Cash from Investing | 43.42M | -255.52M | 72.12M | 55.42M | 60.85M | 49.85M | 42.95M | 24.05M | 47.76M | -46.72M | -315.21M | -171.16M | 11.65M | 1.16M | 52.57M | 31.21M | 23.07M | 25.28M | 10.38M | -18.94M |
| Capital Expenditures | -1.67M | -3.18M | -1.64M | -993K | -440K | -728K | -265K | -756K | 618K | -274K | -344K | -666K | -157K | -410K | -585K | -235K | -345K | -673K | -575K | -354K |
| CapEx % of Revenue | - | 14450% | 10926.67% | 1324% | - | 99.73% | 38.13% | 64.34% | 19.37% | 10.97% | 220.51% | 16.12% | 10.35% | 152.99% | 60.5% | 14.57% | 84.77% | 412.88% | 330.46% | 105.99% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -585K | -11.8M | 0 | 0 | 0 | 69K | 0 | 0 | 2K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -288K | 0 | 0 | 0 | 0 | -1.16M | 0 | 0 | 585K | 11.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.11M | 324.66M | 327K | 1.35M | 774K | 63K | 202K | 386K | 1.24M | 3.71M | 436.11M | 217.37M | 257K | 133K | 694K | 1.4M | 2.31M | 71K | 304K | 426K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.11M | 324.66M | 327K | 1.35M | 774K | 63K | 202K | 386K | 1.24M | 3.71M | 432.3M | 217.37M | 257K | 133K | 694K | 1.4M | 2.31M | 71K | 304K | 426K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -20.5M | 11.72M | 6.86M | -7.17M | 12.99M | 5.91M | -11.22M | -8.04M | -6.34M | -72.34M | 80.26M | 13.68M | -7.09M | -25.9M | 24.69M | 10.85M | -9.82M | 3.11M | -13.85M | -33.04M |
| Free Cash Flow | -66.7M | -60.59M | -67.23M | -64.93M | -49.07M | -44.73M | -54.64M | -33.23M | -54.72M | -29.6M | -40.98M | -33.2M | -19.15M | -27.61M | -29.15M | -22M | -35.54M | -22.92M | -25.11M | -14.88M |
| FCF Margin % | - | -275404.55% | -448180% | -86577.33% | - | -6127.81% | -7861.44% | -2828.26% | -1714.79% | -1184.99% | -26270.51% | -803.66% | -1262.36% | -10300.75% | -3014.89% | -1363.73% | -8731.45% | -14059.51% | -14430.46% | -4454.19% |
| FCF Growth % | -35.94% | -35.45% | -23.04% | -95.39% | 10.33% | -51.12% | -33.32% | -0.1% | -185.74% | -7.23% | -40.57% | -50.93% | 46.11% | -20.46% | -16.11% | -47.86% | -114.63% | -89.82% | -34.63% | -172.57% |
| FCF per Share | -0.85 | -0.78 | -1.01 | -0.98 | -0.74 | -0.67 | -0.82 | -0.50 | -0.83 | -0.45 | -0.70 | -0.64 | -0.41 | -0.58 | -0.62 | -0.47 | -0.76 | -0.49 | -0.54 | -0.32 |
| FCF Conversion (FCF/Net Income) | 0.86x | 0.78x | 0.83x | 0.79x | 0.73x | 0.78x | 1.01x | 0.69x | 1.31x | 0.82x | 1.24x | 0.75x | 0.50x | 0.89x | 0.97x | 0.82x | 1.31x | 0.62x | 1.06x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |